Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hassel

Showing results (21-30 of 321) with videos related to

Pageof 33
Sort By:
Breast Care (Basel, Switzerland)|December 5, 2019
Prophylaxis and Management of Skin ToxicitiesMartin Salzmann, Frederik Marmé, Jessica C Hassel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2021
IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapyR Gutzmer, V Sibaud, J C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 10, 2023
Unterschiedliches Ansprechen auf PD-L1-Inhibition bei fortgeschrittenem Merkelzellkarzinom und kutanem PlattenepithelkarzinomMartin Salzmann, Christoph Löser, Jessica C Hassel
Oncology Research and Treatment|June 5, 2016
Immunotherapy of MelanomaCarolin Bender, Jessica C Hassel, Alexander Enk
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C Hassel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2021
Corrigendum to 'IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy': Annals of Oncology 2021; volume 32: 696-697R Gutzmer, V Sibaud, J C Hassel
Cancers|October 14, 2022
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous RituximabChristian Menzer, Adriana Rendon, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 17, 2023
Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinomaMartin Salzmann, Christoph Löser, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|June 23, 2023
[Fertility preservation in patients with melanoma-a huge relief for those affected]Carola Berking, Jessica C Hassel, Elisabeth Livingstone
Clinical Nuclear Medicine|November 7, 2015
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With PembrolizumabChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
Pageof 33

Showing results (21-30 of 321) with videos related to

Sort By:
Pageof 33
Breast Care (Basel, Switzerland)|December 5, 2019
Prophylaxis and Management of Skin ToxicitiesMartin Salzmann, Frederik Marmé, Jessica C Hassel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2021
IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapyR Gutzmer, V Sibaud, J C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 10, 2023
Unterschiedliches Ansprechen auf PD-L1-Inhibition bei fortgeschrittenem Merkelzellkarzinom und kutanem PlattenepithelkarzinomMartin Salzmann, Christoph Löser, Jessica C Hassel
Oncology Research and Treatment|June 5, 2016
Immunotherapy of MelanomaCarolin Bender, Jessica C Hassel, Alexander Enk
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C Hassel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2021
Corrigendum to 'IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy': Annals of Oncology 2021; volume 32: 696-697R Gutzmer, V Sibaud, J C Hassel
Cancers|October 14, 2022
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous RituximabChristian Menzer, Adriana Rendon, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 17, 2023
Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinomaMartin Salzmann, Christoph Löser, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|June 23, 2023
[Fertility preservation in patients with melanoma-a huge relief for those affected]Carola Berking, Jessica C Hassel, Elisabeth Livingstone
Clinical Nuclear Medicine|November 7, 2015
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With PembrolizumabChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
Pageof 33